Navigation Links
Thesan Pharmaceuticals gibt Serie-A-Finanzierung unter gemeinsamer Führung von Novo Ventures und Novartis Venture Funds bekannt
Date:10/30/2012

SAN DIEGO, 31. Oktober 2012 /PRNewswire/ -- Thesan Pharmaceuticals gab den Abschluss einer Serie-A-Finanzierung in Höhe von 16 Millionen $ bekannt, welche von Novo Ventures und Novartis Venture Funds gemeinsam geführt wird.  Das Unternehmen wird sich auf die Entwicklung von neuartigen Ansätzen für die Behandlung von dermatologischen Erkrankungen konzentrieren. Der führende Medikamentenkandidat des Unternehmens ist eine neue, topisch angewandte, chemische Substanz, die im Jahr 2013 in das klinische Stadium gebracht werden soll.

„Die Medikamentenentwicklung im dermatologischen Bereich sah für viele Jahre so aus, dass alte Medikamente mit einer neuen Rezeptur, die für eine ansprechende Form wie Schaum, Gel oder Lotion sorgte, neu zusammengesetzt wurde", erklärte Gordon Foulkes, der geschäftsführende Vorstand und CEO von Thesan. „Es ist Thesans Ziel, neue chemische Substanzen mit neuartigen Wirkmechanismen zu entwickeln, um die Behandlung von Patienten mit zahlreichen verschiedenen dermatologischen Erkrankungen zu verbessern." 

Die ersten Produkte des Unternehmens wurden von der University of California, Irvine (UCI) lizensiert. Die Produkte wurden im Labor von Professor Daniele Piomelli entwickelt, der den Lehrstuhl Louise Turner Arnold Chair of Neurosciences an der UCI inne hat und Leiter des Bereichs Arzneimittelforschung und -entwicklung am Istituto Italiano di Tecnologia (IIT), Genua (Italien) ist.  

„Wir freuen uns Teil der Investorengemeinschaft hinter Thesan zu sein", erklärte Peter Bisgaard, Partner von Novo Ventures. „Wir sind der Meinung, dass die Arbeit von Professor Piomelli eine einzigartige Möglichkeit zur Entwicklung einer vollständig neuen Klasse von entzündungshemmenden Wirkstoffen darstellt, welche schnell das Stadium der klinischen Entwicklung erreichen. Darüber hinaus freuen wir uns darauf, mit Professor Pio
'/>"/>

SOURCE Thesan Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Thesan Pharmaceuticals Announces Series A Funding Co-Led By Novo Ventures And Novartis Venture Funds
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
4. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
5. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
6. Icahn Issues Statement Regarding Amylin Pharmaceuticals
7. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
8. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
9. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
10. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
11. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... -- Hearing health affects a man,s lifestyle, and if he ... professionally engaged, he should address any hearing loss he may ... Better Hearing Institute (BHI) is delivering to men around ... , which leads up to and includes Father,s Day. This ... June 16. To help men address their ...
(Date:5/23/2013)... -- A recently published clinical study conducted at TOPS Comprehensive ... demonstrates that 3D mammography (breast tomosynthesis) significantly reduces unnecessary ... The study, "Implementation of Breast Tomosynthesis in a Routine ... Stephen L. Rose , MD, and published ... of Roentgenology (AJR). The AJR is the scientific ...
(Date:5/23/2013)... Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly ... property developed and owned by Hadassah University Hospital, ... center, today announced that its portfolio company, Cell ... Israeli Ministry of Industry and Commerce, Office of ... and advance clinical trials. Cell Cure,s development budget ...
Breaking Medicine Technology:Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... blood,pressure, reduces blood flow in the brains of adults ... at the annual meeting of,the Radiological Society of North ... of Alzheimer,s disease, our study,shows that it is another ... effects of the disease," said study co-author Cyrus Raji, ...
... 28 Immunosyn,Corporation (OTC Bulletin Board: IMYN) today ... MHRA to import base material,and manufacture SF-1019 for ... for which Immunosyn holds the exclusive license for,worldwide ... Regulatory Agency," more,commonly known as the MHRA, functions ...
Cached Medicine Technology:High Blood Pressure May Heighten Effects of Alzheimer's Disease 2Immunosyn Announces Biozyme Lab's Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019 2Immunosyn Announces Biozyme Lab's Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019 3
(Date:5/24/2013)... E-Dentists.com has announced the launch of their new ... a leading medical Internet marketing agency. , ... focus on providing dentists the help they need to ... keywords. The dental SEO analysis covers a full analysis ... their competitors are doing right. The goal is to ...
(Date:5/24/2013)... Started in 1982, AMTC’s SHINE event is a ... AMTC’s 31st anniversary. SHINE is a ministry run by three ... and her daughter, Carey Lewis Arban. , This summer’s SHINE ... music professionals including the New York Film Academy, The New ... kings of Hollywood and Christian casting directors. They seek ...
(Date:5/24/2013)... Utah (PRWEB) May 24, 2013 Amirsys ... with exciting new enhancements for instructors and students. Instructors ... more focused through personalize learning plan templates, targeted reading ... release provides 500 new assessment questions, 5,000 searchable anatomy ... notes. , AnatomyOne 2.0 is the first ...
(Date:5/24/2013)... Dwell Media LLC announces ... Executive Vice President of Digital for Dwell Media. At ... a large portion of Yahoo's global media business. At ... a fully-integrated commerce unit to launch in 2014. Huff ... content for leading firms in Silicon Valley. Dwell, which ...
(Date:5/24/2013)... (HealthDay News) -- Low-income, minority parents have more ... are more open to vaccinating their daughters against ... new study contends. Conversely, white, middle-class parents ... their daughters, according to researchers from the Boston ... will get an HPV-related cancer each year, many ...
Breaking Medicine News(10 mins):Health News:Dental SEO Analysis Launched by E-Dentists.com in Partnership with JD Media Surge 2Health News:AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013 2Health News:Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans 2Health News:Yahoo Commerce Head Joins Leadership at Dwell Media 2Health News:Low-Income, Minority Parents More Open to HPV Vaccine for Girls, Study Says 2
... PCYC ) today announced that it will ... 2008 financial results and achievements on,Thursday, April 24, ... To participate in the conference call, please ... callers and reference,conference passcode, 43624853. To access the ...
... in addressing the problem, ALEXANDRIA, Va., April ... the only national organization,representing physician assistants (PA) in ... in on the challenges outlined in the,Institute of ... workforce,and aging baby boomers. There are an estimated ...
... the male hormone in the morning made more money , , ... Britain finds that financial traders who wake up with high ... money that day, probably because they feel more daring. ... the stress hormone cortisol tend to be more cautious. , ...
... DETROIT, April 14 A unique global conference,focusing ... Detroit June 8 - 10,2009. The HealthQuake Summit ... world to gather and explore the ongoing and ... areas of business, policy, and,science/technology that will make ...
... Passover, ATLANTA, April 14 As Americans travel ... for Disease Control,and Prevention advises all travelers to ensure ... measles outbreak in Israel., Since September, more than ... about 700 cases in the cities of Jerusalem and ...
... half the risk of needing to start treatment , , ... levels of the antioxidant urate in their blood appear to ... lower levels do, a new report says. , The findings, ... Neurology , support early laboratory studies about urate,s protective qualities ...
Cached Medicine News:Health News:Health Care Workforce Experts Available to Comment on IOM Report on Aging Baby Boomers and Impending Medical System Crisis 2Health News:Testosterone Levels Among Financial Traders Affect Performance 2Health News:Testosterone Levels Among Financial Traders Affect Performance 3Health News:CDC Urges Travelers to Israel to Protect Themselves from Measles 2Health News:Elevated Urate Levels May Slow Parkinson's in Men 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: